PSI CRO AG’s Post

When you model beyond human ability, you unlock the power of reaching trial milestones on time and budget. Learn how VISIONAL™ helped PSI identify the optimal mix of countries and sites with similar experience and access to a hard-to-recruit subpopulation of breast cancer patients. https://bit.ly/3QfAp63

The tides of support for whole person oncology are turning. While the integration of complementary therapies into cancer care demands a shift in mindset and a commitment to early and open communication, we have an opportunity to change care delivery. Learn what this means for providers in my recent article on KevinMD.com written with #HealingAndCancerBook co-author, Alyssa McManamon, MD, where we discuss this milestone moment in the journey of #WholePerson cancer care. https://bit.ly/3UOOgD9

The tides of support for whole person oncology are turning. While the integration of complementary therapies into cancer care demands a shift in mindset and a commitment to early and open communication, we have an opportunity to change care delivery. Learn what this means for providers in my recent article on KevinMD.com written with #HealingAndCancerBook co-author, Alyssa McManamon, MD, where we discuss this milestone moment in the journey of #WholePerson cancer care. https://bit.ly/3UOOgD9

📚Celebrating ISOPP Member Publications!📚 Jill Kolesar (Lexington, United States): Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer - Cancers. Apr 2024. https://lnkd.in/gDNNM2H3 Fiorenza Enrico (Piossasco (Turin), Italy): A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL) - Frontiers in Oncology. Apr 2024. https://lnkd.in/gktXEstZ Carlo DeAngelis (Toronto, Canada), Flay Charbonneau (Toronto, Canada): 2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients - Supportive Care in Cancer. Apr 2024. https://lnkd.in/gnBkW7yi

The process of finding and participating in a clinical trial can be crazy hard, as Bess Bess Stillman, M.D. and Jake Seliger capture so well in each of their descriptions of Jake's experience with head and neck cancer. Making this process easier is obviously a win-win-win (patients-investigators-sponsors). What can we do, as an industry, to make this happen? In the very-near term, for starters, I hope we'll see more sponsors revising traditional inclusion criteria to make studies more inclusive, facilitating easier access (e.g., childcare, transportation, flexible clinic hours) and gathering more patient input on trial designs. 84% of large Pharma companies currently have a public policy commitment to increase diversity in clinical trials. When it's this hard for a white guy to find and enroll in the study of his choice, expanding diversity is clearly a heavy lift. This is an all-hands-on-deck call to action for the clinical research ecosystem.

Clinical trial treatments at UW Health | Carbone Cancer Center have given Gary Davey more time to create new memories with his family. About 14 years after he was first diagnosed with prostate cancer, Gary now has no evidence of disease and leads an active lifestyle. Check out this video to hear more about Gary's treatments: https://lnkd.in/gdSz8EdR #prostatecancer #clinicaltrials #cancerresearch

🚀 New YouTube Session Alert: Sinonasal Malignancy Part 1 🎥 I’m excited to share the first part of my new YouTube series on sinonasal malignancy. This session delves into the complexities of diagnosing and managing sinonasal malignancies, with a focus on providing practical insights for medical professionals. 🔍 Key Topics Covered: • Overview of sinonasal malignancies • Symptoms and initial diagnosis • Diagnostic imaging and techniques 👩⚕️👨⚕️ Whether you’re a seasoned ENT specialist or a medical student, this series is designed to enhance your understanding and approach to these challenging cases. https://lnkd.in/eREyC2-c

mSMART guidelines for myeloma are now available to download as PowerPoint slides - Vincent Rajkumar https://lnkd.in/eHJWvkPe #oncodaily #oncology #cancer #research